| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | HORIZON PHARMA PLC | 11,684,801 | 253,210,000 | 10.26% | ||
| 2 | NXSTAGE MED INC COM | 4,589,000 | 100,545,000 | 4.07% | ||
| 3 | DYAX CORP COM CVR | 2,242,073 | 84,347,000 | 3.42% | ||
| 4 | Adeptus Health Inc | 1,307,908 | 71,307,000 | 2.89% | ||
| 5 | GLAXOSMITHKLINE PLC | 1,675,385 | 67,602,000 | 2.74% | ||
| 6 | AETNA INC NEW | 591,465 | 63,949,000 | 2.59% | ||
| 7 | DAVITA INC | 822,000 | 57,302,000 | 2.32% | ||
| 8 | MYLAN N V | 1,056,000 | 57,098,000 | 2.31% | ||
| 9 | VANDA PHARMACEUTICALS INC COM | 5,996,691 | 55,829,000 | 2.26% | ||
| 10 | GILEAD SCIENCES INC | 532,000 | 53,833,000 | 2.18% | Call | |
| 11 | TEVA PHARMACEUTICAL INDS LTD | 815,000 | 53,497,000 | 2.17% | ||
| 12 | FLAMEL TECHNOLOGIES SA SPONSORED ADR | 4,072,809 | 49,729,000 | 2.02% | ||
| 13 | HEALTHWAYS INC | 51,925,000 | 49,087,000 | 1.99% | PRN | |
| 14 | ARRAY BIOPHARMA INC 3 06/01/2020 | 45,000,000 | 42,292,000 | 1.71% | PRN | |
| 15 | GLOBAL BLOOD THERAPEUTICS IN COM | 1,163,811 | 37,626,000 | 1.52% | ||
| 16 | HEARTWARE INTL INC | 39,226,000 | 37,364,000 | 1.51% | PRN | |
| 17 | ARRAY BIOPHARMA INC COM | 8,729,361 | 36,838,000 | 1.49% | ||
| 18 | TEVA PHARMACEUTICAL INDS LTD | 550,000 | 36,102,000 | 1.46% | Call | |
| 19 | PORTOLA PHARMACEUTICALS INC | 683,749 | 35,179,000 | 1.43% | ||
| 20 | SAGE THERAPEUTICS | 598,854 | 34,913,000 | 1.41% | ||
| 21 | ENDOLOGIX INC | 40,941,000 | 34,602,000 | 1.40% | PRN | |
| 22 | XENOPORT INC | 6,287,374 | 34,518,000 | 1.40% | ||
| 23 | AAC HLDGS INC COM | 1,782,094 | 33,967,000 | 1.38% | ||
| 24 | INFINITY PHARMACEUTICALS INC COM | 4,305,288 | 33,797,000 | 1.37% | ||
| 25 | UNIVERSAL AMERN CORP NEW | 4,789,027 | 33,523,000 | 1.36% | ||
| 26 | WALGREENS BOOTS ALLIANCE INC | 386,457 | 32,909,000 | 1.33% | ||
| 27 | EHEALTH INC COM | 3,264,588 | 32,581,000 | 1.32% | ||
| 28 | ENDOLOGIX INC | 30,000,000 | 32,548,000 | 1.32% | PRN | |
| 29 | HEALTHWAYS INC | 2,465,042 | 31,725,000 | 1.29% | ||
| 30 | ACCURAY INC | 30,511,000 | 30,875,000 | 1.25% | PRN | |
| 31 | CHARLES RIV LABS INTL INC | 377,188 | 30,322,000 | 1.23% | ||
| 32 | Nivalis Therapeutics Inc | 3,732,412 | 28,889,000 | 1.17% | ||
| 33 | MCKESSON CORP | 144,646 | 28,529,000 | 1.16% | ||
| 34 | GENOMIC HEALTH INC COM | 809,432 | 28,492,000 | 1.15% | ||
| 35 | PACIRA BIOSCIENCES INC | 371,000 | 28,489,000 | 1.15% | ||
| 36 | FIVE PRIME THERAPEUTICS INC | 680,000 | 28,220,000 | 1.14% | ||
| 37 | KEMPHARM INC | 1,420,497 | 28,211,000 | 1.14% | ||
| 38 | ProNAi Therapeutics, Inc. | 1,791,255 | 26,940,000 | 1.09% | ||
| 39 | RELYPSA INC | 900,281 | 25,514,000 | 1.03% | ||
| 40 | SPECTRANETICS CORP | 29,831,000 | 22,537,000 | 0.91% | PRN | |
| 41 | GW PHARMACEUTICALS PLC | 310,122 | 21,535,000 | 0.87% | ||
| 42 | CYTOMX THERAPEUTICS INC COM | 946,022 | 19,743,000 | 0.80% | ||
| 43 | AERIE PHARMACEUTICALS INC | 807,875 | 19,672,000 | 0.80% | ||
| 44 | Proteon Therapeutics | 1,265,343 | 19,625,000 | 0.80% | ||
| 45 | RITE AID CORP | 2,492,772 | 19,543,000 | 0.79% | ||
| 46 | REGENXBIO INC COM | 1,169,042 | 19,406,000 | 0.79% | ||
| 47 | XENCOR INC COM | 1,256,612 | 18,372,000 | 0.74% | ||
| 48 | PACIFIC BIOSCIENCES CALIF IN | 1,388,000 | 18,224,000 | 0.74% | ||
| 49 | ACHILLION PHARMACEUTICALS INC COM | 1,667,000 | 17,987,000 | 0.73% | ||
| 50 | FLUIDIGM CORP DEL | 27,715,000 | 17,603,000 | 0.71% | PRN |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001140361-16-053179, filed 2016.02.16).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
